142 related articles for article (PubMed ID: 1586718)
1. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.
Arsura M; Introna M; Passerini F; Mantovani A; Golay J
Blood; 1992 May; 79(10):2708-16. PubMed ID: 1586718
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
4. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
[TBL] [Abstract][Full Text] [Related]
5. c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B-myb gene, does not correlate with proliferation.
Piccinini G; Luchetti MM; Caniglia ML; Carossino AM; Montroni M; Introna M; Gabrielli A
J Invest Dermatol; 1996 Jun; 106(6):1281-6. PubMed ID: 8752671
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells.
Golay J; Capucci A; Arsura M; Castellano M; Rizzo V; Introna M
Blood; 1991 Jan; 77(1):149-58. PubMed ID: 1984793
[TBL] [Abstract][Full Text] [Related]
7. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
11. Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Hijiya N; Catani L; DeRiel K; Luger SM; McGlave P; Gewirtz AM
Blood; 1992 Apr; 79(8):1956-61. PubMed ID: 1562723
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb.
Pitsch RJ; Goodman GR; Minion DJ; Madura JA; Fox PL; Graham LM
J Vasc Surg; 1996 May; 23(5):783-91. PubMed ID: 8667499
[TBL] [Abstract][Full Text] [Related]
13. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
Simons M; Rosenberg RD
Circ Res; 1992 Apr; 70(4):835-43. PubMed ID: 1551207
[TBL] [Abstract][Full Text] [Related]
14. Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.
Valtieri M; Venturelli D; Caré A; Fossati C; Pelosi E; Labbaye C; Mattia G; Gewirtz AM; Calabretta B; Peschle C
Blood; 1991 Mar; 77(6):1181-90. PubMed ID: 1705831
[TBL] [Abstract][Full Text] [Related]
15. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?
Nieborowska-Skórska M; Nakashima M; Ratajczak M; Steplewski Z; Calabretta B; Skórski T
Folia Histochem Cytobiol; 1994; 32(1):35-40. PubMed ID: 8026602
[TBL] [Abstract][Full Text] [Related]
18. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
19. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.
Sala A; Calabretta B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10415-9. PubMed ID: 1438227
[TBL] [Abstract][Full Text] [Related]
20. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]